RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Manhattan Scientifics Stock

Manhattan Scientifics ROCE 2025

Manhattan Scientifics ROCE

0.39

Ticker

MHTX

ISIN

US5631221000

WKN

911936

In 2025, Manhattan Scientifics's return on capital employed (ROCE) was 0.39, a -63.28% increase from the 1.06 ROCE in the previous year.

Manhattan Scientifics Aktienanalyse

What does Manhattan Scientifics do?

Manhattan Scientifics Inc is an innovative company that operates in the world of science and technology. The company was founded in 1994 by Marvin Maslow and is based in New York City. It primarily focuses on developing advanced technologies in the fields of materials science, biotechnology, and medical technology. The business model of Manhattan Scientifics Inc is based on the discovery and development of new technologies, which are then licensed or sold. The company specializes in technology development and works closely with scientific institutions and researchers around the world. In the past, the company has collaborated closely with NASA and the Los Alamos National Laboratory, and has been able to bring several successful products to market. The various divisions of Manhattan Scientifics Inc include nanotechnology, biotechnology, and medical technology. In the field of nanotechnology, the company has developed advanced technologies for the production of ultralight, highly strong materials. These materials are used in aerospace, construction, and other industries where lightweight and durable materials are needed. The biotechnology division of Manhattan Scientifics Inc focuses on the development of novel therapies for cancer and other diseases. The company has successfully developed a new cancer therapy based on magnetic nanoparticles. These nanoparticles are introduced into the body and attach to cancer cells. They are then attracted and killed by an external magnetic field. Medical technology is another important division of Manhattan Scientifics Inc. The company has developed advanced technologies for the production of medical devices that provide more precise surgeries and treatments. One of Manhattan Scientifics Inc's successful innovations is a device that can precisely target tumors with high-energy radiation to destroy them. Manhattan Scientifics Inc has brought several successful products to market in the past. One example of such a product is the Greenshift Corporation System, which helps reduce emissions from airplanes. The company has also had successful collaborations with NASA on various projects, including the development of super-lightweight carbon fiber components. Overall, Manhattan Scientifics Inc is an innovative company that specializes in the development of new technologies. The company has successfully worked in various fields, including nanotechnology, biotechnology, and medical technology. Its business model is based on the discovery and development of new technologies, which are then licensed or sold. Through its collaborations with scientific institutions and researchers around the world, the company has developed and brought several successful products to market. Manhattan Scientifics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Manhattan Scientifics's Return on Capital Employed (ROCE)

Manhattan Scientifics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Manhattan Scientifics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Manhattan Scientifics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Manhattan Scientifics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Manhattan Scientifics stock

What is the ROCE (Return on Capital Employed) of Manhattan Scientifics this year?

The ROCE of Manhattan Scientifics is 0.39 undefined this year.

How has the ROCE (Return on Capital Employed) of Manhattan Scientifics developed compared to the previous year?

The ROCE of Manhattan Scientifics has increased by -63.28% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Manhattan Scientifics?

A high Return on Capital Employed (ROCE) indicates that Manhattan Scientifics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Manhattan Scientifics?

A low ROCE (Return on Capital Employed) can indicate that Manhattan Scientifics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Manhattan Scientifics impact the company?

An increase in the ROCE of Manhattan Scientifics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Manhattan Scientifics affect the company?

A decrease in ROCE of Manhattan Scientifics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Manhattan Scientifics?

Some factors that can affect Manhattan Scientifics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Manhattan Scientifics so important for investors?

The ROCE of Manhattan Scientifics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Manhattan Scientifics take to improve the ROCE?

To improve the ROCE, Manhattan Scientifics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Manhattan Scientifics pay?

Over the past 12 months, Manhattan Scientifics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Manhattan Scientifics is expected to pay a dividend of 0 USD.

What is the dividend yield of Manhattan Scientifics?

The current dividend yield of Manhattan Scientifics is .

When does Manhattan Scientifics pay dividends?

Manhattan Scientifics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Manhattan Scientifics?

Manhattan Scientifics paid dividends every year for the past 0 years.

What is the dividend of Manhattan Scientifics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Manhattan Scientifics located?

Manhattan Scientifics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Manhattan Scientifics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Manhattan Scientifics from 10/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2025.

When did Manhattan Scientifics pay the last dividend?

The last dividend was paid out on 10/6/2025.

What was the dividend of Manhattan Scientifics in the year 2024?

In the year 2024, Manhattan Scientifics distributed 0 USD as dividends.

In which currency does Manhattan Scientifics pay out the dividend?

The dividends of Manhattan Scientifics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Manhattan Scientifics

Our stock analysis for Manhattan Scientifics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Manhattan Scientifics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.